Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Clinical trial NCT05826535 · RECRUITING

Trial details

NCT number: NCT05826535
Sponsor: Lyell Immunopharma, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma Large B-cell Lymphoma

Start date: 2023-05-09
Primary completion: 2028-12-31
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.